• Genpharmasec Ltd board meeting scheduled for 21 May 2026 to approve FY26/Q4 financial results.
• Trading window closed from 1 April 2026 until 48 hours after result declaration for insiders.
• Disclosure made under SEBI LODR Regulations 29 and 33 for regulatory compliance.